ALS Association Greater New York Chapter Founding President and CEO Dorine...
NEW YORK Sept. 14 2016 PRNewswire Today the ALS Association Greater New York Chapter announced Founding President and CEO Dorine Gordon will retire after 23 years in the position effective September...
View ArticleImedex and ESMO's Annual Gastrointestinal Cancer Congress Reports Record Year...
ESMO 18th World Congress on Gastrointestinal Cancer Surpasses 3500 AttendeesAlpharetta Georgia PRWEB September 14 2016 Investigators and healthcare professionals from the gastrointestinal cancer...
View ArticleSpecialty Pharmacy Times Announces Newest Addition to their Strategic...
NEW alliance will inform and update Specialty Pharmacy Times readers about innovations in specialty pharmacy growth strategy and talent acquisition solutionsPLAINSBORO N.J. PRWEB September 14 2016...
View ArticleCelgene Announces Interim Topline Data from Trial of Investigational Oral...
Monday September 12th 2016 at 1130am UTC Data show endoscopic improvement and clinical response and remission at week 12 Safety and tolerability consistent with previous studies Results expected to be...
View Article180 Medical Named One of the 2016 Best Places to Work in Oklahoma
This is the seventh year in a row 180 Medical made the annual list created by okc.BIZ and Best Companies Group.Oklahoma City OK PRWEB September 15 2016 180 Medical a medical supply company based in...
View ArticleSoligenix to Present at 2016 Aegis Growth Conference
PRINCETON N.J. Sept.&160;15 2016 PRNewswire &160;Soligenix Inc. OTCQB SNGX Soligenix or the Company a latestage biopharmaceutical company focused on developing and commercializing products to...
View ArticleImmune Pharmaceuticals Signs Agreement to Fund Maxim Pharmaceuticals Inc. its...
NEW YORK Sept. 16 2016 PRNewswire &160;Immune Pharmaceuticals Inc. NASDAQ IMNP "Immune" or the "Company" a biopharmaceutical company focused on the development of targeted therapeutics for the...
View ArticleBRIEFJanssen receives CHMP positive opinion for Stelara Ustekinumab
Janssen receives CHMP positive opinion for StelaraUstekinumab recommending approval for the treatment ofmoderately to severely active Crohn's disease in the EuropeanUnion
View ArticleFavorable Benefit Risk Profile for Vedolizumab as Induction and Maintenance...
OSAKA Japan Sept. 16 2016 PRNewswire Takeda Pharmaceutical Company Limited TSE 4502 "Takeda" announced that an exploratory analysis of the GEMINI 1 data evaluating...
View ArticleMolecular switch controlling immune suppression may help turn up immunotherapies
Researchers at University of California San Diego School of Medicine and Moores Cancer Center have identified a strategy to maximize the effectiveness of anticancer immune therapy. The researchers...
View ArticleTiGenix Business and Financial Update for the First Half 2016
PRESS RELEASERegulated information TiGenix Business and Financial Update for the First Half 2016 Conference call and webcast today at 1000am CET Leuven BELGIUM September 20 2016 0700h CET TiGenix NV...
View ArticleStelara wins EU backing for Crohns indication
Advisors to the European Medicines Agency are backing approval of Janssen's Stelara bringing the drug closer to becoming the first interleukin1223 inhibitor licensed for Crohn's disease.
View ArticleImmunotherapy Boosted by Discovery of Molecular Switch
Exploiting the body’s immune system to fight progressive pathological conditions such as cancer Crohn’s and Alzheimer’s is the basis for novel immunotherapy compounds that...
View ArticleSensitive Clinical Marker Defined for Ulcerative Colitis Evolution
The two main subtypes of inflammatory bowel diseases IBD Crohns disease CD and ulcerative colitis UC are characterized by episodes...
View ArticleSherman Prize for Excellence in Crohn's and Colitis Announces 2016 Award...
WASHINGTON Sept. 20 2016 PRNewswireUSNewswire &160;The Bruce and Cynthia Sherman Charitable Foundation today announced the 2016 recipients of the inaugural Sherman Prize for Excellence in Crohn's...
View ArticleNew therapeutic target for Crohn's disease
Research from the Sanford Burnham Prebys Medical Discovery Institute SBP identifies a promising new target for future drugs to treat inflammatory bowel disease IBD. The study published today in Cell...
View ArticleMaxor Announces Intent to Acquire Pharmaceutical Specialties Inc. PSI...
AMARILLO Texas Sept. 20 2016 PRNewswire Maxor National Pharmacy Services LLC "Maxor" today announced an agreement to acquire Pharmaceutical Specialties Inc. "PSI".&160; The combination of...
View ArticleZealand sponsored educational symposium highlights the need for better...
Press release No. 5 2016 Zealand sponsored educational symposium highlights the need for better medical treatment of short bowel syndrome Short bowel syndrome is a serious and undertreated orphan...
View ArticleTeam identifies fungus in humans for first time as key factor in Crohn's disease
A Case Western Reserve University School of Medicineled team of international researchers has for the first time identified a fungus as a key factor in the development of Crohn's disease. The...
View ArticleGlobal Digestive Health Food and Drinks Market 20162020
LONDON Sept. 20 2016 PRNewswire About Digestive Health Food and DrinksDigestive health food and drinks are products designed to ease the symptoms or discomfort associated with an overburdened digestive...
View Article